BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32452986)

  • 1. Bilateral Corneal Graft Rejection Associated With Pembrolizumab Treatment.
    Vanhonsebrouck E; Van De Walle M; Lybaert W; Kruse V; Roels D
    Cornea; 2020 Nov; 39(11):1436-1438. PubMed ID: 32452986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for corneal allograft rejection: intermediate results of a prospective normal-risk keratoplasty study.
    Küchle M; Cursiefen C; Nguyen NX; Langenbucher A; Seitz B; Wenkel H; Martus P; Naumann GO
    Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):580-4. PubMed ID: 12136292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo Confocal Microscopy Demonstrates Increased Immune Cell Densities in Corneal Graft Rejection Correlating With Signs and Symptoms.
    Chirapapaisan C; Abbouda A; Jamali A; Müller RT; Cavalcanti BM; Colon C; Witkin D; Sahin A; Dana R; Cruzat A; Hamrah P
    Am J Ophthalmol; 2019 Jul; 203():26-36. PubMed ID: 30790547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten-year postoperative results of penetrating keratoplasty.
    Ing JJ; Ing HH; Nelson LR; Hodge DO; Bourne WM
    Ophthalmology; 1998 Oct; 105(10):1855-65. PubMed ID: 9787355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corneal endothelium and postoperative outcomes 15 years after penetrating keratoplasty.
    Patel SV; Hodge DO; Bourne WM
    Am J Ophthalmol; 2005 Feb; 139(2):311-9. PubMed ID: 15733993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term comparison of full-bed deep lamellar keratoplasty with penetrating keratoplasty in treating corneal leucoma caused by herpes simplex keratitis.
    Wu SQ; Zhou P; Zhang B; Qiu WY; Yao YF
    Am J Ophthalmol; 2012 Feb; 153(2):291-299.e2. PubMed ID: 21996306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel cyclosporine a drug-delivery system for prevention of human corneal rejection after high-risk keratoplasty: a clinical study.
    Shi W; Chen M; Xie L; Liu M; Gao H; Wang T; Wu X; Zhao J
    Ophthalmology; 2013 Apr; 120(4):695-702. PubMed ID: 23246118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An endothelial rejection line following Descemet stripping automated endothelial keratoplasty.
    Alkhalifah M; Alqahtani B; Almulhim A; Alsarhani W
    BMC Ophthalmol; 2020 Jul; 20(1):307. PubMed ID: 32727405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term changes in corneal endothelial cell density after repeat penetrating keratoplasty in eyes with endothelial decompensation.
    Hayashi K; Kondo H; Maeno A; Takimoto M
    Cornea; 2013 Jul; 32(7):1019-25. PubMed ID: 23328699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and Clinical Course of Immune Reactions after Descemet Membrane Endothelial Keratoplasty: Retrospective Analysis of 1000 Consecutive Eyes.
    Hos D; Tuac O; Schaub F; Stanzel TP; Schrittenlocher S; Hellmich M; Bachmann BO; Cursiefen C
    Ophthalmology; 2017 Apr; 124(4):512-518. PubMed ID: 28094043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interim results from the prospective "Erlanger Non-high-risk Penetrating Keratoplasty Study" in 207 patients].
    Graupner M; Seitz B; Langenbucher A; Martus P; Blüthner K; Nguyen NX; Wenkel H; Küchle M
    Klin Monbl Augenheilkd; 2000 Sep; 217(3):163-70. PubMed ID: 11076347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graft rejection following descemet stripping automated endothelial keratoplasty: features, risk factors, and outcomes.
    Wu EI; Ritterband DC; Yu G; Shields RA; Seedor JA
    Am J Ophthalmol; 2012 May; 153(5):949-957.e1. PubMed ID: 22265142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty.
    Nguyen NX; Seitz B; Martus P; Langenbucher A; Cursiefen C
    Am J Ophthalmol; 2007 Aug; 144(2):318-9. PubMed ID: 17659972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicted long-term outcome of corneal transplantation.
    Borderie VM; Boëlle PY; Touzeau O; Allouch C; Boutboul S; Laroche L
    Ophthalmology; 2009 Dec; 116(12):2354-60. PubMed ID: 19815285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pembrolizumab-induced severe rejection and graft intolerance syndrome resulting in renal allograft nephrectomy.
    Padala SA; Patel SK; Vakiti A; Patel N; Gani I; Kapoor R; Muhammad S
    J Oncol Pharm Pract; 2021 Mar; 27(2):470-476. PubMed ID: 32580640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary graft failure associated with epithelial downgrowth: a case report.
    Aldave AJ; Hollander DA; Branco B; Crawford B; Abbott RL
    BMC Ophthalmol; 2005 May; 5():11. PubMed ID: 15916712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep anterior lamellar keratoplasty using acellular corneal tissue for prevention of allograft rejection in high-risk corneas.
    Li J; Yu L; Deng Z; Wang L; Sun L; Ma H; Chen W
    Am J Ophthalmol; 2011 Nov; 152(5):762-70.e3. PubMed ID: 21803324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft rejection and failure following endothelial keratoplasty (DSAEK) and penetrating keratoplasty for secondary endothelial failure.
    Pedersen IB; Ivarsen A; Hjortdal J
    Acta Ophthalmol; 2015 Mar; 93(2):172-7. PubMed ID: 25130326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft rejection after Descemet's stripping automated endothelial keratoplasty: graft survival and endothelial cell loss.
    Li JY; Terry MA; Goshe J; Shamie N; Davis-Boozer D
    Ophthalmology; 2012 Jan; 119(1):90-4. PubMed ID: 22115709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic immunosuppression with mycophenolate mofetil to prevent corneal graft rejection after high-risk penetrating keratoplasty: a 2-year follow-up study.
    Szaflik JP; Major J; Izdebska J; Lao M; Szaflik J
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):307-14. PubMed ID: 26553197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.